Wendell David Associates’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-8,000
Closed -$794K 155
2019
Q3
$794K Sell
8,000
-1,390
-15% -$132K 0.12% 97
2019
Q2
$868K Sell
9,390
-4,985
-35% -$473K 0.13% 94
2019
Q1
$1.36M Sell
14,375
-63,985
-82% -$5.6M 0.21% 85
2018
Q4
$5.02M Sell
78,360
-2,420
-3% -$179K 0.9% 36
2018
Q3
$7.23M Sell
80,780
-660
-0.8% -$58.3K 1.13% 28
2018
Q2
$6.47M Sell
81,440
-4,650
-5% -$386K 1.1% 28
2018
Q1
$7.68M Sell
86,090
-6,935
-7% -$666K 1.38% 23
2017
Q4
$9.71M Buy
93,025
+290
+0.3% +$32.7K 1.66% 20
2017
Q3
$13.5M Buy
92,735
+3,735
+4% +$509K 2.39% 10
2017
Q2
$11.6M Sell
89,000
-1,215
-1% -$149K 2.18% 15
2017
Q1
$11.2M Sell
90,215
-1,770
-2% -$212K 2.15% 14
2016
Q4
$10.6M Buy
91,985
+270
+0.3% +$30.1K 2.1% 14
2016
Q3
$9.59M Buy
91,715
+125
+0.1% +$13.5K 1.89% 17
2016
Q2
$9.07M Sell
91,590
-1,315
-1% -$136K 1.78% 16
2016
Q1
$9.29M Buy
92,905
+590
+0.6% +$60.8K 1.8% 18
2015
Q4
$11.1M Buy
92,315
+1,720
+2% +$199K 2.19% 14
2015
Q3
$9.78M Sell
90,595
-1,070
-1% -$133K 2.01% 15
2015
Q2
$10.6M Sell
91,665
-1,475
-2% -$169K 2.06% 16
2015
Q1
$10.7M Buy
93,140
+990
+1% +$118K 2.06% 15
2014
Q4
$10.3M Buy
92,150
+1,610
+2% +$170K 2.01% 15
2014
Q3
$8.6M Buy
90,540
+2,480
+3% +$224K 1.79% 21
2014
Q2
$7.57M Buy
88,060
+8,290
+10% +$630K 1.59% 22
2014
Q1
$5.58M Buy
79,770
+4,430
+6% +$351K 1.21% 28
2013
Q4
$6.37M Buy
75,340
+700
+0.9% +$55.4K 1.4% 25
2013
Q3
$5.75M Buy
74,640
+580
+0.8% +$40.6K 1.38% 25
2013
Q2
$4.33M Buy
+74,060
New +$4.46M 1.08% 28

Other funds holding CELG

Wendell David Associates's CELG Position: Q4 2019 in Review

Wendell David Associates sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 8,000 shares — an estimated $794K sold.

Wendell David Associates first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $13.5M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Wendell David Associates reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Wendell David Associates sold 8,000 Celgene Corp shares in Q4 2019, an estimated $794K.
  • Wendell David Associates first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Wendell David Associates's Celgene Corp position peaked at $13.5M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Wendell David Associates's 13F filing for Q4 2019, filed 17 Jan 2020.